Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Ulcerative Colitis

NCT02914535 is registered in ClinicalTrials.gov with Alfasigma S.p.A. as lead sponsor.

NCT NCT02914535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02914535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Ulcerative Colitis
Lead sponsor
Alfasigma S.p.A.
Phase
Phase 3
Overall status
Completed
Start date
February 23, 2017
Completion date
September 8, 2026
Enrollment
1,173 (actual)
Sites
323

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis